109518 ⎘
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME
#2MATURATION OF DENDRITIC CELLS
#3METHOD TO CHANGE THE POLARIZATION OF TUMOR ASSOCIATED MACROPHAGES BY EXPOSING THEM TO A SOURCE OF RADIATION IN THE PRESENCE OF MAGNETOSOMES
#4COMPOSITIONS AND METHODS FOR IMPROVED NK CELL THERAPIES
#5SIRPa DEFICIENT MACROPHAGES FOR TREATING CANCER
#6MACROPHAGE-BASED THERAPY
#7METHODS OF ENRICHING CELL POPULATIONS FOR CANCER-SPECIFIC T CELLS USING IN VITRO STIMULATION OF MEMORY T CELLS
#8INDUCED PLURIPOTENT STEM CELLS (IPSC), T-CELL COMPOSITIONS AND METHODS OF USE
#9CELL CULTURE MEDIA AND METHODS FOR GENERATING HUMAN ALVEOLAR MACROPHAGE-LIKE CELLS
#10METHOD OF GENERATING iPS CELL AND iPS CELL GENERATION SYSTEM
#11NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES
#12Dendritic cell generating apparatus and method
#13Method for Producing Naive Human IPS Cells From Somatic Cells
#14METHOD FOR PRODUCING REGENERATED T CELL VIA IPS CELL
#15COMPOSITIONS AND METHODS FOR MODELING HUMAN MICROGLIA
#16METHOD FOR PREPARING DENDRITIC CELL USING PLATELET LYSATE
#17NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING BLOOD TO INDUCED PLURIPOTENT STEM CELLS
#18METHOD OF PRODUCING MACROPHAGES
#19SIRPa Deficient Macrophages for Treating Cancer
#20NOVEL METHOD
#21PREPARATION METHOD OF TROPHOBLASTS WITH LIMITED GENERATIONS, CULTURE METHOD OF SNK CELLS AND METHOD FOR TREATING TUMOR
#22MEDIUM COMPOSITION FOR CULTURING T CELLS AND METHOD FOR CULTURING T CELLS USING SAME
#23REPROGRAMMING CELLS INTO HOMEOSTATIC MICROGLIA
#24Novel RNA Composition and Production Method for Use in iPS Cell Generation
#25Dendritic cell generating apparatus and method
#26Cell culture media and methods for generating human alveolar macrophage-like cells
#27EX VIVO GENERATION OF IMMUNOCYTES RECOGNIZING BROTHER OF THE REGULATOR OF IMPRINTED SITES (BORIS) EXPRESSING CANCER STEM CELLS
#28COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME
#29BOVINE MONOCYTE-DERIVED MACROPHAGE IN CULTURE SYSTEM AND METHODS FOR MEASURING INNATE IMMUNITY
#30COMPOSITION FOR TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF
#31METHOD FOR PREPARING MATURE RED BLOOD CELLS IN VITRO USING PERIPHERAL BLOOD
#32MUTATED INTERLEUKIN-34 (IL-34) POLYPEPTIDES AND USES THEREOF IN THERAPY
#33Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
#34CD11B + PIEZO-1 + MACROPHAGES AND USES THEREOF
#35USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS
#36TISSUE-ENGINEERED THREE-DIMENSIONAL MODEL FOR TUMOR ANALYSIS
#37Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells
#38Progenitor cells of mesodermal lineage
#39Immortalization of Splenic and Peripheral Blood Macrophages Using a Multi-Cistronic V-RAF/V-MYC Lentivirus
#40Method of selectively differentiating undifferentiated macrophage into M1 macrophage
#41Macrophage-based therapy
#42Methods for nuclear reprogramming of cells
#43Dendritic cell generating apparatus and method
#44Dendritic cell generating apparatus and method
#45Maturation of dendritic cells
#46Progenitor cells of mesodermal lineage
#47Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#48METHODS OF GENERATING HEPATIC MACROPHAGES AND USES THEREOF
#49METHOD FOR INDUCING TRANSDIFFERENTIATION OF IMMUNE CELLS BASED ON EXOSOMES
#50Cancer vaccines and vaccination methods
#51Efficient method for reprogramming blood to induced pluripotent stem cells
#52Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#53Generation of antigen-specific TCRs
#54Dendritic cell composition
#55Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
#56Tissue-engineered three-dimensional model for tumor analysis
#57Method for differentiating induced pluripotent stem cells, which are prepared from endocardium-derived adult stem cells, into cardiovascular cells, and use thereof
#58Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction
#59Enrichment of CD16+ monocytes to improve dendritic cell vaccine quality
#60Cell therapy with polarized macrophages for tissue regeneration
#61Compositions and methods for reprogramming adult cells through the stemness of a platelet rich fraction of blood containing platelet-like cells in humans
#62CD11 B[low] MACROPHAGES AND CONDITIONED MEDIA THEREOF FOR TREATING CANCER AND/OR FIBROSIS
#63Co-differentiation of monocytes from allogeneic donors
#64Use of PDL1 expressing cells to convert T cells into regulatory T cells
#65Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
#66Method of producing microglial cells
#67METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS
#68Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#69METHOD FOR OBTAINING IMMUNO-SUPPRESSIVE DENDRITIC CELLS
#70Cancer vaccines and vaccination methods
#71Tolerogenic dendritic cells, method for their production and uses therof
#72Methods and compositions for treating breast cancer with dendritic cell vaccines
#73OVARIAN CANCER VACCINES AND VACCINATION METHODS
#74METHOD OF GENERATING MULTILINEAGE POTENTIAL CELLS
#75CD11 B[low] macrophages and conditioned media thereof for treating cancer and/or fibrosis
#76Co-differentiation of monocytes from allogeneic donors
#77SELECTING FETAL BOVINE SERUM FOR USE IN STEM CELL CULTURE MEDIA AND PREPARING STEM CELL CULTURE
#78Method for obtaining monocytes or NK cells
#79Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear cells
#80Methods of evaluating immunogenicity of an agent using an artificial tissue construct
#81Dendritic Cell Compositions and Methods
#82Method for in vitro differentiation of blood circulating cells into neuronal-like cells and applications thereof
#83Methods for nuclear reprogramming of cells
#84Progenitor cells of mesodermal lineage
#85Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine
#86Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes
#87Compositions and methods for producing dendritic cells
#88Method for producing cells having characteristics of hepatocytes
#89METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#90Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytes
#91Dendritic cell compositions and methods
#92Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#93Monocyte-Derived Stem Cells (MDSC) and Methods of Use Thereof
#94Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#95USE OF PARASYMPATHOLYTIC SUBSTANCES TO ENHANCE AND ACCELERATE STEM CELL DIFFERENTIATION, RELATED METHODS AND COMPOSITIONS
#96Tolerogenic dendritic cells, method for their production and uses therof
#97Dendritic cell compositions and methods
#98Human Stem Cell Materials and Methods
#99Monocyte-origin multipotent cell MOMC
#100Human stem cell materials and methods
#101COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19
#102COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19
#103COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19